ChengDa Pharmaceuticals Co. Ltd. (301201) — Financial Flexibility Index
ChengDa Pharmaceuticals Co. Ltd. (301201) has a Financial Flexibility Index of 0.41x as of December 2025. Free cash flow of CN¥103.04 Million (operating CF CN¥34.02 Million minus capex CN¥69.02 Million) represents 0% of total liabilities (CN¥252.83 Million). Check ChengDa Pharmaceuticals Co. Ltd. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ChengDa Pharmaceuticals Co. Ltd. Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for ChengDa Pharmaceuticals Co. Ltd. across 7 annual periods. For the full cash flow conversion analysis, see 301201 operating cash flow.
Annual Financial Flexibility Index for ChengDa Pharmaceuticals Co. Ltd. (2019–2025)
Year-by-year free cash flow to debt coverage for ChengDa Pharmaceuticals Co. Ltd.. Explore ChengDa Pharmaceuticals Co. Ltd. (301201) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.41x | CN¥103.04 Million | CN¥34.02 Million | CN¥252.83 Million | ▼ -62.4% |
| 2024 | 1.08x | CN¥315.01 Million | CN¥28.65 Million | CN¥290.77 Million | ▼ -54.1% |
| 2023 | 2.36x | CN¥416.74 Million | CN¥192.07 Million | CN¥176.40 Million | ▼ -1.3% |
| 2022 | 2.39x | CN¥253.36 Million | CN¥47.67 Million | CN¥105.81 Million | ▲ +65.5% |
| 2021 | 1.45x | CN¥221.84 Million | CN¥83.14 Million | CN¥153.30 Million | ▼ -43.5% |
| 2020 | 2.56x | CN¥192.78 Million | CN¥128.97 Million | CN¥75.30 Million | ▲ +308.5% |
| 2019 | 0.63x | CN¥118.59 Million | CN¥67.52 Million | CN¥189.21 Million | — |